Deep venous thrombosis: Outpatient management is now FDA approved

Journal of Thrombosis and Thrombolysis

Volumn 7, Issue 2, 1999, Pages 113-122

  Baron, Rebecca M ^a   Goldhaber, Samuel Z ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Anticoagulation; Deep venous thrombosis; Outpatient treatment

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ARTICLE; CONTINUOUS INFUSION; DEEP VEIN THROMBOSIS; DRUG BIOAVAILABILITY; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; OUTPATIENT CARE; PRIORITY JOURNAL; SIDE EFFECT;

ANTICOAGULANTS; FIBRINOLYTIC AGENTS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INFUSIONS, INTRAVENOUS; OUTPATIENTS; PRACTICE GUIDELINES; QUALITY ASSURANCE, HEALTH CARE; TRIAGE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VENOUS THROMBOSIS; WARFARIN;

EID: 0032907090     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008873201503     Document Type: Article

References (22)

1. Hull R, Raskob GE, Rosenbloom D, et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 1990;322(18):1260-1264.
2. Rooke TW, Osmundon PJ. Heparin and the in-hospital management of deep venous thrombosis: Cost considerations. Mayo Clinic Proc 1986;61:198-204.
3. Barritt DS, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism: A controlled trial. Lancet 1960;1:1309-1312.
4. Hull R, Delmore T, Genton E, et al. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med 1979;301(16):855-858.
5. Hull R, Delmore T, Carter C, et al. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. N Engl J Med 1982;306(4):189-94.
6. Lagerstedt CI, Olsson CG, Fagher BO, Oqvist BW, Albrechtsson U. Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 1985;2(8454): 515-518.
7. Brandjes DP, Heijboer H, Buller HR, de Rijk M, Jagt H, ten Cate JW Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. N Engl J Med 1992;327(21):1485-1489.
8. Hull RD, Raskob GE, Hirsh J, et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med 1986;315(18):1109-1114.
9. Pearson SD, Lee TH, McCabe-Hassan S, Dorsey JL, Goldhaber SZ. A Critical pathway to treat lower-extremity deep vein throbosis. Am J Med 1996;100:283-289.
10. Schoenenberger RA, Pearson SD, Goldhaber SZ, Lee TH. Variation in the management of deep venous thrombosis: Implications for the potential impact of a critical pathway. Am J Med 1996;100:278-282.
11. Hirsch DR, Lee TH, Morrison RB, Carlson W, Goldhaber S Shortened hospitalization by means of adjusted-dose subcutaneous heparin for deep venous thrombosis. Am Heart J 1996;131:276-280.
12. Doyle DJ, Turpie AG, Hirsh J, et al. Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis: A randomized trial. Ann Intern Med 1987;107(4):441-445.
13. Hommes DW, Bura A, Mazzolai L, Buller HR, ten Cate JW. Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis: A meta-analysis. Ann Int Med 1992; 116:279-284.
14. Bounameaux H, Goldhaber SZ. Uses of low-molecular-weight heparin. Blood Reviews 1995;9:213-219.
15. Hassoun PM, Thompson BT, Hales CA. Partial reversal of hypoxic pulmonary hypertension by heparin. Am Rev Respir Dis 1992;145:193-196.
16. Thompson BT, Spence CR, Janssens SP, Joseph PM, Hales CA. Inhibition of hypoxic pulmonary hypertension by heparins of differing in vitro antiproliferation potency. Am J Respir Crit care Med 1994;149(6):1512-1517.
17. Koopman MMW, Prandoni P, Piorella F, et al. Treatment of venous thrombosis with intravenous unfractionated heparin as compared with subcutaneous low molecular weight heparin administered at home. N Engl J Med 1996:334:682-687.
18. Levine MA, Gent M, Hirsh J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334: 677-681.
19. Goldhaber SZ, Morrison RB, Diran LL, et al. Abbreviated hospitalization for deep venous thrombosis with the use of ardeparin. Arch Intern Med 1998;158:2325-2328.
20. Schulman S, Rhedin AS, Lindmarker P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism: Duration of Anticoagulation Trial Study Group. N Engl J Med 1995; 332(25):1661-1665.
21. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125(1):1-7.
22. Brandjes DPM, Buller HR, Heijboer H, Huisman MV, de Rijk M, Jagt H, ten Cate JW Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997;349;759-762.